Perceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy

England, Lucinda J.; Tong, Van T.; Koblitz, Amber; Kish-Doto, Julia; Lynch, Molly; Southwell, Brian

doi:10.1016/j.pmedr.2016.09.002

Cited by 55 publications

(45 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…EVPs are perceived as safer than cigarettes, especially during high-risk conditions such as pregnancy (12–16). A small study of pregnant women who attended a university’s outpatient clinic found that 43% of participants believed that EVPs were less harmful to a fetus than conventional cigarettes, and 57% believed that EVPs contained nicotine (18).…”

Section: Discussionmentioning

confidence: 99%

“…Despite increased use of these products in recent years and the risks of use during pregnancy, little is known about public perceptions about the use of these products, particularly among pregnant women. Some studies found that EVPs were perceived as a safer alternative to smoking cigarettes, including during pregnancy (12–16). These studies were small in size and limited to specific populations such as a university-based outpatient clinic.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

US Adults’ Perceptions of the Harmful Effects During Pregnancy of Using Electronic Vapor Products Versus Smoking Cigarettes, Styles Survey, 2015

et al. 2016

Self Cite

View full text Add to dashboard Cite

IntroductionResearch suggests aerosol from electronic vapor products (EVPs) has fewer harmful constituents than conventional cigarette smoke. Even so, EVPs and other nicotine-containing products are not safe to use during pregnancy. We examined perceptions among US adults regarding harm in using EVPs rather than smoking cigarettes during pregnancy.MethodsData came from the 2015 Styles Survey, an Internet panel survey of a sample of US adults aged 18 years or older (N = 4,127). Perceived harm was assessed by asking respondents whether using EVPs was less, equally, or more harmful for pregnant women than smoking cigarettes. Descriptive statistics were used to estimate perceived harm overall and by sociodemographic characteristics and tobacco-use status. Perceived harm was assessed among all adults, women of reproductive age (18–44 years, n = 820), and women of nonreproductive age (≥45 years, n = 1,398).ResultsAmong all adults, 11.1% believed using EVPs during pregnancy was less harmful than smoking conventional cigarettes, 51.0% believed it was equally harmful, 11.6% believed it was more harmful, and 26.2% did not know. Prevalence of perception of less harm, by demographic category, was greatest among adults aged 18 to 24 years, men, non-Hispanic whites, adults with less than a high school diploma, current EVP users, and current cigarette smokers (P < .05). Prevalence of perception of less harm was greater among women of reproductive age (9.6%) than among those of nonreproductive age (7.9%) (P < .05).ConclusionUS adults have varying levels of perceptions about the harms of EVP use versus cigarette smoking during pregnancy. Efforts are warranted to prevent nicotine exposure during pregnancy and to educate adults on the dangers of using any form of tobacco during pregnancy, including EVPs.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

US Adults’ Perceptions of the Harmful Effects During Pregnancy of Using Electronic Vapor Products Versus Smoking Cigarettes, Styles Survey, 2015

et al. 2016

Self Cite

View full text Add to dashboard Cite

show abstract

“…Nicotine, the dependence‐producing drug in ECIGs, is a toxicant of particular concern for pregnant women, as nicotine is known to harm a fetus (e.g., Bruin, Gerstein, & Holloway, ; England et al, ) some have suggested that no amount of nicotine in pregnancy is safe (CDC, ; Suter, Mastrobattista, Sachs, & Aagaard, ). ECIGs differ dramatically in terms of their nicotine delivery, with some products delivering little to no nicotine (e.g., Farsalinos et al, 2014; Vansickel et al, 2010; Yan & D'Ruiz, 2015), and others delivering as much, or more, than a combustible cigarette (e.g., Ramoa et al, 2016; St. Helen, Havel, Dempsey, Jacob III, & Benowitz, ; Wagner et al, ).…”

Section: Do Ecigs Deliver Nicotine and Other Toxicants?mentioning

confidence: 99%

“…In addition to the two primary themes of ECIGs being safer than cigarettes and ECIGs being smoking cessation aids, researchers have noted additional factors related to ECIG use among pregnant women, including the perceived ability to use ECIGs in otherwise smoke-free areas (England et al, 2016), a lower product cost (Bowker et al, 2018;England et al, 2016), the appeal of various flavors (England et al, 2016;Fallin, Miller, Assef, & Ashford, 2016), especially sweet flavors (Stroud, Papandonatos, Borba, Kehoe, & Scott-Sheldon, 2019), and the lack of awareness of nicotine content in the ECIG liquid (Kahr et al, 2015;Kapaya et al, 2019). Interestingly, women also express a desire for credible information related to ECIG safety, specifically from healthcare providers (Bowker et al, 2018).…”

Section: What Are Pregnant Women's Perceptions About Ecigs?mentioning

confidence: 99%

Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery

Breland

McCubbin

Ashford

2019

Birth Defects Research

View full text Add to dashboard Cite

Electronic nicotine delivery systems (ENDS), which includes e‐cigarettes (ECIGs), are a rapidly‐expanding class of products that heat a liquid (which may or may not contain nicotine) to produce an aerosol. The variation of ECIG components is extensive as are their effects on users. Epidemiological data show that while both adults and youth use ECIGs, use among youth has increased dramatically in recent years. Other epidemiological data show that women of reproductive age and some pregnant women are also using ECIGs. The goal of this article is to provide readers with background information about ECIGs, with a focus on recent findings about ECIG use in pregnancy and potential implications. Among pregnant women, correlates of ECIG use include current cigarette smoking, among other factors. Regarding pregnant women's perceptions of ECIG use in pregnancy, two themes emerge from the literature: many pregnant women perceive ECIGs to be safer than conventional cigarettes, and that ECIGs can aid with smoking cessation. In contrast to these perceptions, there is little concrete evidence that ECIGs help smokers quit. In addition, there are concerns about ECIG nicotine and other toxicant delivery. Nicotine is a toxicant of particular concern for pregnant women, as nicotine is known to harm a developing fetus. There are many limitations to existing research, and the literature is scant in this area. Further, new “pod mod”‐style ECIGs such as JUUL present new challenges. Overall, with limited evidence of their effectiveness, and concerns about developmental toxicology, the authors do not recommend that pregnant women use ECIGs.

show abstract

“…In the last decade, the overall use of cigarettes has declined significantly; however, over 10% of pregnant women still smoke during pregnancy, and there is an increased trend towards using non‐combusted tobacco products (snuff, dissolvable, and electronic nicotine delivery systems) that can deliver nicotine during pregnancy (England et al . , ). Nicotine replacement therapies, e.g.…”

Section: Introductionmentioning

confidence: 99%

Pre‐ and early postnatal nicotine exposure exacerbates autoresuscitation failure in serotonin‐deficient rat neonates

Lee

Sirieix

Nattie

et al. 2018

The Journal of Physiology

View full text Add to dashboard Cite

Cigarette smoking during pregnancy increases the risk of sudden infant death syndrome (SIDS), and nicotine replacements, a key ingredient of cigarettes, have been recently prescribed to women who wish to quit smoking during their pregnancy. Serotonin (5-HT) abnormalities have been consistently identified in many SIDS cases. Here we investigated the effects of perinatal nicotine exposure in mild 5-HT deficiency rat neonates on autoresuscitation, a protective cardiorespiratory reflex. The mild 5-HT deficiency was induced by a maternal tryptophan-deficient diet, and nicotine was delivered from embryonic day (E) 4 to postnatal day (P) 10 at 6 mg kg day through an osmotic pump. In P10 rats, nicotine exposure exacerbates autoresuscitation failure (mortality) in mildly 5-HT-deficient rats to a greater extent than in controls (P = 0.029). The recovery of eupnoea and heart rate to baseline values following repetitive anoxic events (which elicit an apnoea accompanied by a bradycardia) is significantly delayed in 5-HT-deficient rats treated with nicotine, making them more susceptible to failure of autoresuscitation (eupnoea recovery: P = 0.0053; heart rate recovery: P = < 0.0001). Neither 5-HT deficiency nor nicotine exposure alone appears to affect the ability to autoresuscitate significantly when compared among the four treatments. The increased vulnerability to environmental stressors, e.g. severe hypoxia, asphyxia, or anoxia, in these nicotine-exposed 5-HT-deficient neonates during postnatal developmental period is evident.

show abstract

Perceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy

Cited by 55 publications

References 5 publications

US Adults’ Perceptions of the Harmful Effects During Pregnancy of Using Electronic Vapor Products Versus Smoking Cigarettes, Styles Survey, 2015

US Adults’ Perceptions of the Harmful Effects During Pregnancy of Using Electronic Vapor Products Versus Smoking Cigarettes, Styles Survey, 2015

Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery

Pre‐ and early postnatal nicotine exposure exacerbates autoresuscitation failure in serotonin‐deficient rat neonates

Contact Info

Product

Resources

About